| Price | 505.00p on 16-04-2026 at 17:50:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 530.00p |
| Sell | 480.00p |
| Last Trade: | Buy 3.00 at 530.00p |
| Day's Volume: | 4 |
| Last Close: | 505.00p |
| Open: | 505.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 505.00p - 505.00p |
| 52wk Range: | 474.00p - 1,140.00p |
| Market Capitalisation: | £78.20m |
| VWAP: | 530.00p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3 | 530.00p | Ordinary |
14:12:34 - 16-Apr-26 |
| Buy* | 1 | 530.00p | SI Trade |
14:12:34 - 16-Apr-26 |
| Sell* | 500 | 482.50p | Ordinary |
16:08:55 - 15-Apr-26 |
| Buy* | 141 | 528.88p | Ordinary |
12:34:51 - 15-Apr-26 |
| Buy* | 26 | 530.00p | Ordinary |
11:21:11 - 15-Apr-26 |
| Buy* | 955 | 523.45p | Ordinary |
16:26:03 - 14-Apr-26 |
| Buy* | 19 | 523.45p | Ordinary |
08:20:58 - 14-Apr-26 |
| Buy* | 9 | 550.00p | Suspected BUY Trade |
16:35:29 - 13-Apr-26 |
| Sell* | 659 | 509.90p | Ordinary |
16:09:22 - 13-Apr-26 |
| Unknown* | 2,000 | 500.00p | Ordinary |
15:34:27 - 13-Apr-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Mar 2026 7:00 am | PRN | Lease of Manufacturing Facility |
| 12th Mar 2026 7:00 am | PRN | Appointment of COO |
| 3rd Mar 2026 7:00 am | PRN | Appointment of CCO |
| 16th Feb 2026 7:00 am | PRN | Director Dealing |
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
